-
Patent Agency Ranking
公开(公告)号：WO2020250033A1
公开(公告)日：2020-12-17
申请号：PCT/IB2020/000443
申请日：2020-06-09
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor： PALUMBO, Antonio , ALLIKMETS, Kristina , BERG, Deborah , FEDYK, Eric
IPC: A61K39/395 , C07K16/28 , A61K31/573
Abstract: Methods of administering isolated anti-CD38 antibodies in combination with lenalidomide or pomobdomide, and dexamethasone and, optionally, bortezomib, for the treatment of multiple myeloma.
-
公开(公告)号：WO2019186273A1
公开(公告)日：2019-10-03
申请号：PCT/IB2019/000314
申请日：2019-03-27
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor： FEDYK, Eric , HANLEY, Michael , PALUMBO, Antonio
Abstract: Methods of administering isolated anti-CD38 antibodies subcutaneously are disclosed. The methods provide an effective treatment for autoimmune diseases and cancers, including hematologic diseases. Also disclosed are unit dosage forms for the anti-CD38 antibodies.
-
公开(公告)号：WO2019186273A4
公开(公告)日：2019-10-03
申请号：PCT/IB2019/000314
申请日：2019-03-27
Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventor： FEDYK, Eric , HANLEY, Michael , PALUMBO, Antonio
Abstract: Methods of administering isolated anti-CD38 antibodies subcutaneously are disclosed. The methods provide an effective treatment for autoimmune diseases and cancers, including hematologic diseases. Also disclosed are unit dosage forms for the anti-CD38 antibodies.
-
公开(公告)号：EP3980064A1
公开(公告)日：2022-04-13
申请号：EP20737529.6
申请日：2020-06-09
Applicant: Takeda Pharmaceutical Company Limited
Inventor： PALUMBO, Antonio , ALLIKMETS, Kristina , BERG, Deborah , FEDYK, Eric
IPC: A61K39/395 , C07K16/28 , A61K31/573
-
公开(公告)号：EP3774915A1
公开(公告)日：2021-02-17
申请号：EP19726474.0
申请日：2019-03-27
Applicant: Takeda Pharmaceutical Company Limited
Inventor： FEDYK, Eric , HANLEY, Michael , PALUMBO, Antonio
-
-
-
-
Search Results
5
records
(took 0.022 seconds)
